002294 Shenzhen Salubris Pharmaceuticals
- 28.25
- -0.03-0.11%
Shenzhen Salubris Pharmaceuticals News
Shenzhen Salubris Pharmaceuticals: Announcement on the completion of non-trading transfer and repurchase of shares for the third phase of employee stock ownership plan
Shenzhen Salubris Pharmaceuticals: Announcement Regarding the Release of Pledged Shares by the Controlling Shareholder.
Shenzhen Salubris Pharmaceuticals: Notice of the expiration of the lock-up period for the second phase of employee shareholding plan.
Shenzhen Salubris Pharmaceuticals: Announcement of Annual Equity Distribution Implementation in 2023
Shenzhen Salubris Pharmaceuticals: Announcement on shareholders donating part of the company's shares free of charge to complete the transfer
Shenzhen Salubris Pharmaceuticals: Announcement on the controlling shareholder's partial share pledge and cancellation of the pledge
Xinlitai: Announcement on the cancellation of the pledge of some of the controlling shareholder\'s shares
Xinlitai: Announcement on the controlling shareholder\'s share pledge
Xinlitai: Announcement on the controlling shareholder\'s share pledge
Xinlitai: An indicative announcement on the expiration of the second lockdown period of the second phase of the employee stock ownership plan
Xinlitai: Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Xinlitai: 2022 Annual Equity Distribution Implementation Notice
Xinlitai: Summary Report of Huaying Securities Co., Ltd. on the sponsorship work of Shenzhen Xinlitai Pharmaceutical Co., Ltd.'s non-public offering of A-shares
Xinlitai: Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Xinlitai: Announcement on the controlling shareholder's share pledge
Xinlitai: Announcement on the controlling shareholder's share pledge
Xinlitai: Huaying Securities Co., Ltd.'s opinion on the inspection opinion of Mr. Ye Yuxiang, Chairman of Shenzhen Xinlitai Pharmaceutical Co., Ltd., to participate in the holding subsidiary's equity incentive plan and related transactions under specific c
Xinlitai: Huaying Securities Co., Ltd.'s inspection opinions on the proposed participation of some directors and senior managers of Shenzhen Xinlitai Pharmaceutical Co., Ltd. in the holding subsidiary's equity incentive plan and related transactions
Xinlitai: Verification opinion of Huaying Securities Co., Ltd. on the proposed implementation of equity incentive plans and related transactions by the holding subsidiary of Shenzhen Xinlitai Pharmaceutical Co., Ltd.
Xinlitai: Announcement on Chairman Ye Yuxiang's intention to participate in the holding subsidiary's equity incentive plan and related transactions under specific conditions
Analysis
Price Target
No Data
